149 related articles for article (PubMed ID: 35856238)
1. Immunopathology of COVID-19 and its implications in the development of rhino-orbital-cerebral mucormycosis: a major review.
Dave TV; Nair AG; Joseph J; Freitag SK
Orbit; 2022 Dec; 41(6):670-679. PubMed ID: 35856238
[TBL] [Abstract][Full Text] [Related]
2. Bilateral blindness in a young male of rhino-orbital-cerebral mucormycosis: A case report.
Kaur R; Sehgal A; Khan B; Budhiraja G; Roychoudhury AK; Kaur M
Indian J Ophthalmol; 2022 May; 70(5):1822-1824. PubMed ID: 35502084
[TBL] [Abstract][Full Text] [Related]
3. Rhino-Orbital Cerebral Mucormycosis in Non-Diabetic Patients with COVID-19.
Elhamamsy S; Bayer T; Al-Kaffas M; Hatahet S; Grover M; Samdhani S; Nanda A; Gravenstein S
R I Med J (2013); 2021 Oct; 104(8):19-21. PubMed ID: 34582509
[TBL] [Abstract][Full Text] [Related]
4. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and Pathology of COVID-Associated Mucormycosis: What Is New and Why.
Radotra B; Challa S
Curr Fungal Infect Rep; 2022; 16(4):206-220. PubMed ID: 36193101
[TBL] [Abstract][Full Text] [Related]
6. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
[TBL] [Abstract][Full Text] [Related]
7. Rhino-orbital-cerebral mucormycosis in COVID-19 patients - Taming the black evil with pharmacological weapons.
Kaur K; Gurnani B
Indian J Pharmacol; 2021; 53(5):417-419. PubMed ID: 34854414
[No Abstract] [Full Text] [Related]
8. The ROC Staging System for COVID-related Rhino-Orbital-Cerebral Mucormycosis.
Naik MN; Rath S
Semin Ophthalmol; 2022 Apr; 37(3):279-283. PubMed ID: 34260342
[TBL] [Abstract][Full Text] [Related]
9. Rhino-orbital-cerebral mucormycosis: fungal epidemic in a viral pandemic.
Chouhan M; Solanki B; Shakrawal N
J Laryngol Otol; 2021 Nov; 135(11):981-986. PubMed ID: 34470691
[TBL] [Abstract][Full Text] [Related]
10. Histomorphological features of mucormycosis with rise and fall of COVID-19 pandemic.
Ganesan N; Sivanandam S
Pathol Res Pract; 2022 Aug; 236():153981. PubMed ID: 35749915
[TBL] [Abstract][Full Text] [Related]
11. How Does Mucorales Benefit from the Dysregulated Iron Homeostasis During SARS-CoV-2 Infection?
Lugito NPH; Cucunawangsih C
Mycopathologia; 2021 Dec; 186(6):877-882. PubMed ID: 34623597
[TBL] [Abstract][Full Text] [Related]
12. A clinico-pathological study of COVID-19 associated rhino-orbital-cerebral mucormycosis.
Mani S; Thirunavukkarasu A
Indian J Ophthalmol; 2022 Mar; 70(3):1013-1018. PubMed ID: 35225563
[TBL] [Abstract][Full Text] [Related]
13. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
[TBL] [Abstract][Full Text] [Related]
14. The potential for rapid antigen testing for mucormycosis in the context of COVID-19.
Thornton CR
Expert Rev Mol Diagn; 2024 Mar; 24(3):161-167. PubMed ID: 37405409
[TBL] [Abstract][Full Text] [Related]
15. Magnetic Resonance Imaging in Coronavirus Disease - 2019 Associated Rhino-Orbital-Cerebral Mucormycosis (CA-ROCM) - Imaging Analysis of 50 Consecutive Patients.
Yadav T; Tiwari S; Gupta A; Garg PK; Khera PS; Rajagopal R; Goyal A; Soni K; Chugh A; Jain V; Sureka B; Elhence P; Misra S
Curr Probl Diagn Radiol; 2022; 51(1):112-120. PubMed ID: 34802841
[TBL] [Abstract][Full Text] [Related]
16. Mucormycosis in COVID-19 patients.
Sundaram N; Bhende T; Yashwant R; Jadhav S; Jain A
Indian J Ophthalmol; 2021 Dec; 69(12):3728-3733. PubMed ID: 34827032
[TBL] [Abstract][Full Text] [Related]
17. Study of rhino-orbital-cerebral mucormycosis and its correlates during COVID-19 pandemic in a tertiary eye care institute of central India.
Verma V; Sarkar D; Moharana B; Singh P; Noyadu R; Sharma B
Indian J Ophthalmol; 2023 Dec; 71(12):3669-3676. PubMed ID: 37991302
[TBL] [Abstract][Full Text] [Related]
18. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review.
Nair AG; Dave TV
Orbit; 2022 Jun; 41(3):275-286. PubMed ID: 34720026
[TBL] [Abstract][Full Text] [Related]
19. Rhino-orbito-cerebral mucormycosis in an immunocompetent patient: case report and review of literature.
Shatriah I; Mohd-Amin N; Tuan-Jaafar TN; Khanna RK; Yunus R; Madhavan M
Middle East Afr J Ophthalmol; 2012; 19(2):258-61. PubMed ID: 22623872
[TBL] [Abstract][Full Text] [Related]
20. Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021.
Buil JB; van Zanten ARH; Bentvelsen RG; Rijpstra TA; Goorhuis B; van der Voort S; Wammes LJ; Janson JA; Melchers M; Heusinkveld M; Melchers WJG; Kuijper EJ; Verweij PE
Euro Surveill; 2021 Jun; 26(23):. PubMed ID: 34114540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
